
--- Page 1 ---
Clinical Information HISTORY OF PRESENT ILLNESS Symptoms: Weight lss H emmtia Clinical Findings: Performance Scale (Karnofsky Score):  100 Asymptomatic 80-90 Symptomatic but Fully Ambulatory 60-70 Symptomatic,in bed less than 50% of day 40-50 Symptomatic, in bed more than 50% of day,but not bed ridden 20-30 Bed Ridden CURRENT MEDICATIONS Drug Dose Route Frequency Date (mm/dd/yyyy) To To / To / To / To

--- Page 2 ---
PAST MEDICAL HISTORY Diagnosis/Disease/Disorder/Injury Diagnosis Date Treatment Status Menopausal Status Pre-menopausal Peri-Menopausal Post-menopausal Birth Control:Condom Oral Contraceptive IUD  Hormone Replacement  Other: Therapy: SOCIAL HISTORY Occupation: Environmental Hazards: Smoking History Current Status TYPE Packs/day Duration When Quit YES NO yrs yr Alcohol Consumption Current Status TYPE Drinks/day Duration When Quit YES SNO yrs yr Drug Use Current Status TYPE Frequency Duration When Quit YES NO yrs yr FAMILYMEDICAL HISTORY Relative Diagnosis Age of Diagnosis LABDATA Test Result Test Result Date HIV Negative Positive: CEA Negative Positive: Hep B Negative  Positive: CA 15-3 Negative Positive: Hep C Negative Positive: CA 19-9 Negative Positive: AFP Negative Positive PSA Negative Positive: Other: Other: Negative Positive: Negative Positive: B/T Cell Markers: 2

--- Page 3 ---
DIAGNOSTIC STUDIES Study Results Date Ultrasound  A tmwut was foun in the lefkicneel X-Ray CT Endoscopy MRI Biopsy CLINICAL DIAGNOSIS Location of Suspected Involved Suspected Distant Metastasis Clinical Staging T3 NA Stage: Treatment Information SURGICAL TREATMENT Procedure Date of Procedure ReSeeton eft kidnau Primary Tumor Organ Detailed Location Size eLt Jcidney DemoR 3x 3x2 cm Extension of Tumor Lymph Nodes Description Location of Lymph Nodes # of Lymph Nodes Palpable, Non-Dissected Lymph Nodes Dissected Lymph Nodes Distant Metastasis Organ Detailed Location Size Surgical Staging T 3 NA M Stage: 0 NEOADJUVENT THERAPY (Chemo, Radiation, Immuno, Hormonal, or Molecular) Drug/Treatment Dose Route Frequency Date (mm/dd/yyyy) / To To / To / / / / / To / / / To / 3

--- Page 4 ---
SPECIMEN TYPE (#of samples provided) Frozen Paraffin Block Blood/Serum/Plasma Slide Diseased Normal Diseased Normal Diseased Normal Diseased Normal 2 4 2 2 Time to LN2 Time to Formalin Time to LN2 12 min 13 min min PATHOLOGICALDESCRIPTION Primary Tumor Organ Size Extension of Tumor Distance to NAT efT leidneylumor Rx3x2cm cm Lymph Nodes Location # Examined # Metastasized Distant Metastasis Organ Detailed Location Size Pathological Staging pT3 NA M Stage: TY Notes: 4

--- Page 5 ---
CELL DISTRIBUTION + Diffuse STRUCTURAL PATTERN XStreaming + Mosaic Storiform Necrosis Fibrosis Lymphocytic Infiltration X Palisading Vascular Invasion X Cystic Degeneration Clusterized Bleeding Alveolar Formation Myxoid Change Indian File Psammoma/Calcification 2.Cellular features: Squamous + Adenomatous + Sarcomatous + Lymphomatous Squamoid Cell Glandular cell X Round Cell Large Cell Spindle Cell Cell Stratification Fibroblast Small Cell Keratin Secretion Osteoblast RS CeIVRS Like Desmosome Intracyt.Vacuole Lipoblast Inflam.Cell Pearl Gland formation Myoblast Plasma Cell Otherwise Specified: D7R HeeRos Dr7J D320 Dy707 L 2.Cellular Differentiation: Well Moderately Poor 3.Nuclear Atypia: Nuclear Appearance II Aniso Nucleosis Hyperchromatism Nucleolar Prominent Y Multinucleated Giant Cell Mitotic Activity X Nuclear Grade